Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin

NCT00187707 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Gabapentin

Sponsor

University of California, San Francisco